SANA (Sana Biotechnology, Inc.) Stock Financials & Earnings | Market Cap Arena

SANA (Sana Biotechnology, Inc.) Stock Financials & Earnings | Market Cap Arena

SANASana Biotechnology, Inc.

Mkt Cap$900M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$244M

EPS (TTM)-$0.96

Free Cash Flow (TTM)-$145M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Next: Q1 2026 · Mar 16

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$84M
Q2 23	$0	$0	-$116M
Q3 23	$0	$0	-$2M
Q4 23	$0	$0	-$91M
Q1 24	$0	$0	-$111M
Q2 24	$0	$0	-$49M
Q3 24	$0	$0	-$62M
Q4 24	$0	$0	-$51M
Q1 25	$0	$0	-$51M
Q2 25	$0	$0	-$95M
Q3 25	$0	$0	-$44M
Q4 25	$0	-$3M	-$2M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$79M	-$81M
Q2 23	-$59M	-$60M
Q3 23	-$64M	-$66M
Q4 23	-$52M	-$66M
Q1 24	-$66M	-$81M
Q2 24	-$59M	-$72M
Q3 24	-$52M	-$56M
Q4 24	-$47M	-$48M
Q1 25	-$49M	-$49M
Q2 25	-$33M	-$33M
Q3 25	-$29M	-$29M
Q4 25	-$33M	-$34M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$2M
Q2 23	$2M
Q3 23	$2M
Q4 23	$14M
Q1 24	$16M
Q2 24	$13M
Q3 24	$4M
Q4 24	$436K
Q1 25	$136K
Q2 25	$112K
Q3 25	$41K
Q4 25	$873K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	+165.3%
Q2 23	—	+59.5%
Q3 23	—	-97.5%
Q4 23	—	+10.8%
Q1 24	—	+31.7%
Q2 24	—	-57.5%
Q3 24	—	+2731.8%
Q4 24	—	-43.9%
Q1 25	—	-54.3%
Q2 25	—	+92.4%
Q3 25	—	-29.5%
Q4 25	—	-96.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$9M	—
Q2 23	$10M	—
Q3 23	$9M	—
Q4 23	$8M	—
Q1 24	$9M	—
Q2 24	$11M	—
Q3 24	$11M	—
Q4 24	$6M	—
Q1 25	$7M	—
Q2 25	$7M	—
Q3 25	$0	—
Q4 25	$6M	—

OpEx Breakdown

Quarter	R&D	G&A
Q1 23	$67M	$17M
Q2 23	$100M	$17M
Q3 23	—	$19M
Q4 23	$70M	$21M
Q1 24	$94M	$16M
Q2 24	$33M	$16M
Q3 24	$48M	$14M
Q4 24	$34M	$17M
Q1 25	$39M	$11M
Q2 25	$40M	$10M
Q3 25	$33M	$10M
Q4 25	$20M	$12M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$160M	$189M	$349M
Q2 23	$174M	$152M	$326M
Q3 23	$168M	$100M	$269M
Q4 23	$134M	$72M	$205M
Q1 24	$177M	$134M	$311M
Q2 24	$135M	$117M	$252M
Q3 24	$127M	$72M	$199M
Q4 24	$128M	$25M	$152M
Q1 25	$96M	$9M	$105M
Q2 25	$71M	$1M	$73M
Q3 25	$103M	$50M	$153M
Q4 25	$72M	$67M	$138M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	191M	+0.4%
Q2 23	193M	+0.7%
Q3 23	200M	+4.1%
Q4 23	197M	-1.6%
Q1 24	217M	+10.1%
Q2 24	234M	+7.9%
Q3 24	235M	+0.4%
Q4 24	236M	+0.4%
Q1 25	238M	+0.5%
Q2 25	238M	+0.3%
Q3 25	260M	+9.3%
Q4 25	253M	-2.8%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 18	—	—
FY 19	—	—
FY 20	$0	265
FY 21	$0	383
FY 22	$0	421
FY 23	$0	421
FY 24	$0	194
FY 25	$0	142